Cargando…

A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus

The human respiratory syncytial virus (hRSV) constitutes a major health burden, causing millions of hospitalizations in children under five years old worldwide due to acute lower respiratory tract infections. Despite decades of research, licensed vaccines to prevent hRSV are not available. Developme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díaz, Fabián E., Guerra-Maupome, Mariana, McDonald, Paiton O., Rivera-Pérez, Daniela, Kalergis, Alexis M., McGill, Jodi L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108697/ https://www.ncbi.nlm.nih.gov/pubmed/33981309 http://dx.doi.org/10.3389/fimmu.2021.664212

Ejemplares similares

Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination
por: Guerra-Maupome, Mariana, et al.
Publicado: (2019)

Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves
por: Guerra-Maupome, Mariana, et al.
Publicado: (2019)

Feeding Saccharomyces cerevisiae fermentation products lessens the severity of a viral–bacterial coinfection in preweaned calves
por: McDonald, Paiton O, et al.
Publicado: (2021)

Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves
por: McGill, Jodi L., et al.
Publicado: (2019)

Prophylactic digoxin treatment reduces IL-17 production in vivo in the neonatal calf and moderates RSV-associated disease
por: McGill, Jodi L., et al.
Publicado: (2019)

Current Animal Models for Understanding the Pathology Caused by the Respiratory Syncytial Virus
por: Altamirano-Lagos, María José, et al.
Publicado: (2019)

Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection
por: Guerra-Maupome, Mariana, et al.
Publicado: (2019)

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
por: Abarca, Katia, et al.
Publicado: (2020)

Supplementing a Saccharomyces cerevisiae fermentation product modulates innate immune function and ameliorates bovine respiratory syncytial virus infection in neonatal calves
por: Mahmoud, Asmaa H A, et al.
Publicado: (2020)

Use of Thoracic Ultrasonography to Improve Disease Detection in Experimental BRD Infection
por: Porter, Madison M., et al.
Publicado: (2021)

Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica
por: McGill, Jodi L., et al.
Publicado: (2016)

Recombinant BCG Vaccines Reduce Pneumovirus-Caused Airway Pathology by Inducing Protective Humoral Immunity
por: Soto, Jorge A., et al.
Publicado: (2018)

Development of surface engineered antigenic exosomes as vaccines for respiratory syncytial virus
por: Hong, Suyeon, et al.
Publicado: (2021)

Subcutaneous Bacillus Calmette–Guérin Administration Induces Innate Training in Monocytes in Preweaned Holstein Calves
por: Samuel, Beulah E. R., et al.
Publicado: (2023)

TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine
por: Rey-Jurado, Emma, et al.
Publicado: (2020)

Effects of supplemental Zn concentration and trace mineral source on immune function and associated biomarkers of immune status in weaned beef calves received into a feedlot
por: Smerchek, Dathan T, et al.
Publicado: (2023)

Neonatal Calf Infection with Respiratory Syncytial Virus: Drawing Parallels to the Disease in Human Infants
por: Sacco, Randy E., et al.
Publicado: (2012)

A glycosylated recombinant subunit candidate vaccine consisting of Ehrlichia ruminantium major antigenic protein1 induces specific humoral and Th1 type cell responses in sheep
por: Faburay, Bonto, et al.
Publicado: (2017)

Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia—Implications for Vaccine Design
por: Rey-Jurado, Emma, et al.
Publicado: (2017)

Potential Neurocognitive Symptoms Due to Respiratory Syncytial Virus Infection
por: Andrade, Catalina A., et al.
Publicado: (2021)

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
por: Topalidou, Xanthippi, et al.
Publicado: (2023)

Safety and Immunogenicity of the Recombinant BCG Vaccine AERAS-422 in Healthy BCG-naïve Adults: A Randomized, Active-controlled, First-in-human Phase 1 Trial
por: Hoft, Daniel F., et al.
Publicado: (2016)

Protective Efficacy of BCG Vaccination in Calves Vaccinated at Different Ages
por: Hope, Jayne C., et al.
Publicado: (2023)

Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf
por: McGill, Jodi L., et al.
Publicado: (2018)

Is the BCG Vaccine Safe for Undernourished Individuals?
por: Ishikawa, Larissa Lumi Watanabe, et al.
Publicado: (2012)

Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection
por: Maina, Teresia W., et al.
Publicado: (2023)

Bovine Respiratory Syncytial Virus (BRSV) Infection Detected in Exhaled Breath Condensate of Dairy Calves by Near-Infrared Aquaphotomics
por: Santos-Rivera, Mariana, et al.
Publicado: (2022)

Could BCG Vaccination Induce Protective Trained Immunity for SARS-CoV-2?
por: Covián, Camila, et al.
Publicado: (2020)

Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice
por: Kilpeläinen, Athina, et al.
Publicado: (2019)

Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
por: Pacheco, Gaspar A., et al.
Publicado: (2021)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Identification of a DRB3*011:01-restricted CD4(+) T cell response against bovine respiratory syncytial virus fusion protein
por: Kaplan, Bryan S., et al.
Publicado: (2023)

Specific and non-specific effects of Mycobacterium bovis BCG vaccination in dairy calves
por: Contreras, Catalina, et al.
Publicado: (2023)

Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa
por: Loxton, André G., et al.
Publicado: (2017)

Antibody development for preventing the human respiratory syncytial virus pathology
por: Soto, Jorge A., et al.
Publicado: (2020)

Prevalence of failure of passive immunity transfer in Australian non‐replacement dairy calves
por: Roadknight, N, et al.
Publicado: (2022)

Messenger RNA biomarkers of Bovine Respiratory Syncytial Virus infection in the whole blood of dairy calves
por: Johnston, Dayle, et al.
Publicado: (2021)

BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design
por: Covián, Camila, et al.
Publicado: (2019)

Functional Impairment of Mononuclear Phagocyte System by the Human Respiratory Syncytial Virus
por: Bohmwald, Karen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_i02uekbdnv43eev2vb5rajo455